• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices

Samsung Electronics Co. Ltd.

Samsung eyes stake in Exo Imaging

May 27, 2025 By Danielle Kirsh

Samsung Electronics‘ investment arm is in discussions to join a group of firms backing software and medical device company Exo Imaging, according to a Bloomberg report. The private fundraising round, led by Sands Capital, Bold Capital and Qubit Health Capital, could total about $100 million, Bloomberg reports. Santa Clara, California-based Exo develops handheld ultrasound devices […]

Filed Under: Business/Financial News, Funding Roundup, Imaging Tagged With: Exo Imaging, samsung, Samsung Electronics Co. Ltd.

Samsung could battle Apple over non-invasive glucose monitors

January 23, 2024 By Sean Whooley

Bloomberg reports that Samsung has eyes on developing non-invasive glucose monitoring technology, potentially pitting it against Apple. The report says the electronics company wants to develop continuous blood pressure checking along with glucose monitoring. It comes as part of an effort to incorporate health features in Samsung devices, like its Galaxy Ring, Bloomberg says. Hon Pak, […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Health Technology, Patient Monitoring, Software / IT Tagged With: Apple, samsung, Samsung Electronics Co. Ltd.

FDA clears Samsung Galaxy smart watch for AFib detection

May 11, 2023 By Sean Whooley

Samsung Electronics announced that the irregular heart rhythm notification feature of its health monitor app received FDA clearance. Combined with the app’s existing on-demand ECG function, the feature proactively monitors heart rhythms suggestive of AFib. It all works straight from the user’s wrist through the Samsung Galaxy Watch. “We’re excited to announce that irregular heart […]

Filed Under: Business/Financial News, Cardiovascular, Diagnostics, Digital Health, Featured, Food & Drug Administration (FDA), Health Technology, News Well, Patient Monitoring, Regulatory/Compliance, Software / IT Tagged With: AFib, Samsung Electronics Co. Ltd.

FDA clears mobile CT scanner from Samsung’s NeuroLogica

November 28, 2022 By Sean Whooley

NeuroLogica — a Samsung Electronics subsidiary — announced today that it received FDA 510(k) clearance for its next-gen BodyTom 64 scanner. Danvers, Massachusetts-based NeuroLogica designed its BodyTom 64 for point-of-care mobile computed tomography (CT). BodyTom 64 offers revisions to the company’s software and data acquisition system (DAS) based on customer feedback. For example, NeuroLogica incorporated […]

Filed Under: 510(k), Business/Financial News, Featured, Food & Drug Administration (FDA), Health Technology, Imaging, News Well, Regulatory/Compliance Tagged With: NeuroLogica Corp., Samsung Electronics Co. Ltd.

Samsung wins FDA nod for next-gen RS85A ultrasound

March 23, 2018 By Fink Densford

Samsung Electronics (LON:BC94) subsidiary Samsung NeuroLogica said today it won FDA 510(k) clearance for its RS85A ultrasound device. The RS85A system features new Samsung technology including the MV-Flow feature which allows for the visualization of slow-flow micro vascularized structures and S-Shearwave Imaging technology which quantifies the elasticity of tissue or lesions. The newly cleared system also […]

Filed Under: Business/Financial News, Imaging Tagged With: Samsung Electronics Co. Ltd.

Your fitness tracker could be misleading you

May 30, 2017 By Danielle Kirsh

Your heart rate may be accurate on your fitness tracker, but the number of calories burned is significantly wrong, according to new research from Stanford University. The researchers suggest that although the heart rate measurements are pretty much accurate, energy expenditure measurements are probably significantly wrong. Apple Watch, Basis Peak, Fitbit Surge, Microsoft Band, Mio […]

Filed Under: Digital Health, News Well, Research & Development Tagged With: Apple, Apple Watch, Fitbit, fitnesstrackers, MedTech, Microsoft Corp., Samsung Electronics Co. Ltd., wearables

How virtual and mixed reality are changing drug delivery and device design

February 17, 2017 By Sarah Faulkner

Kai Worrell believes that virtual and mixed reality may change the way companies design medical devices, and he’s putting that idea into practice. “We think it’s going to transform the way we do feasibility testing and cognitive walk-through simulations,” he said. “We think it’s going to help us understand the cognition of our users, clinical […]

Filed Under: Drug-Device Combinations, Research & Development Tagged With: Alphabet (Google), Boston Scientific, Facebook, Johnson and Johnson, Medtronic, Samsung Electronics Co. Ltd., Worrell

Samsung Biologics IPO could reach $2B, company value above $8B

October 4, 2016 By Fink Densford

Biotech drug contract manufacturer Samsung BioLogics could pull in as much as $2 billion through an initial public offering, according to regulatory filings posted this week.  The figures would position it as South Korea’s 3rd-largest IPO. BioLogics, which is 47.8% owned by Samsung Electronics (LON:BC94), this week gave new information on the planned offering, which would value the […]

Filed Under: Business/Financial News Tagged With: Samsung Bioepis Co Ltd, Samsung BioLogics, Samsung Electronics Co. Ltd.

Samsung to spur wearable health tech with ‘bio-processor’ chip

December 29, 2015 By Fink Densford

Samsung Electronics (LON:BC94) today launched its Bio-Processor, a health and fitness monitoring chip which processes 5 different biometric signals, hoping the chip will accelerate development of wearable health tech. The new processor is already in mass production, and is the industry’s 1st all-in-one health solution chip, according to the Japanese electronics giant. “With improvements in […]

Filed Under: Business/Financial News, Diagnostics, Digital Health Tagged With: Samsung Electronics Co. Ltd.

Medtronic expands Samsung deal into neuromod

December 11, 2015 By Fink Densford

Medtronic (NYSE:MDT) said it expanded its strategic partnership with Samsung Electronics (LON:BC94) into the neuromodulation arena, looking to treat chronic pain, movement disorders, incontinence and other conditions. The announcement was made today at the North American Neuromodulation Soceity’s scientific session in Las Vegas. The combination will position Samsung to develop tools on Google‘s (NSDQ:GOOG) Android tablet […]

Filed Under: Business/Financial News, Digital Health, Neurological Tagged With: Medtronic, Samsung Electronics Co. Ltd.

Samsung win FDA 510(k) for digital radiography system

August 7, 2015 By Fink Densford

Samsung Electronics (LON:BC94) subsidiary NeuroLogica said yesterday it won FDA 510(k) clearance for its GC85A digital radiography system. The newly cleared ceiling x-ray unit comes with S-Vue imaging, a wireless S-Detector, mobile system control, smart stiching and other improvements, the company said. “The Samsung GC85A represents NeuroLogica’s latest commitment to introducing user and patient-centric innovation […]

Filed Under: 510(k), Food & Drug Administration (FDA), Imaging, Regulatory/Compliance Tagged With: NeuroLogica Corp., Samsung Electronics Co. Ltd.

  • Page 1
  • Page 2
  • Page 3
  • Go to Next Page »

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy